Type |
Details |
Score |
Publication |
First Author: |
Côté M |
Year: |
2011 |
Journal: |
Nature |
Title: |
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. |
Volume: |
477 |
Issue: |
7364 |
Pages: |
344-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chandrakesan P |
Year: |
2014 |
Journal: |
Oncogene |
Title: |
Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. |
Volume: |
33 |
Issue: |
20 |
Pages: |
2639-54 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The class F scavenger receptors (SCARFs or SRECs) have two isoforms, SCARF1/SREC-I and SCARF2/SREC-II. Similar to SREC-I, SREC-II contains multiple epidermal growth factor-like repeats in its extracellular domain. However, in contrast to SREC-I, SREC-II had little activity to internalize modified low density lipoproteins (LDL). SREC-II and SREC-I display strong heterophilic trans-interaction through the extracellular domains []. They are expressed in a specific temporal and spatial pattern during epidermal development [].Mutations in the SCARF2 gene cause Van den Ende-Gupta syndrome (VDEGS), a syndrome characterised by craniofacial and skeletal abnormalities []. The class F scavenger receptor 1 (SCARF1/SREC-I) contains epidermal growth factor (EGF)-like repeats in its extracellular domain, followed by a long C-terminal cytoplasmic tail composed of serine and proline-rich regions. SCARF1 is an endocytic receptor for acetylated low density lipoprotein, HSP70, HSP90, calreticulin, gp96, and GP2 [, , , , ]. Dendritic cells (DCs), macrophages and endothelial cells use SCARF1 to recognize and engulf apoptotic cells via the complement component C1q; this mediates apoptotic cells clearance, antigen clearance and prevents autoimmunity []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Ishii J |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain. |
Volume: |
277 |
Issue: |
42 |
Pages: |
39696-702 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
141
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Will C |
Year: |
1993 |
Journal: |
J Virol |
Title: |
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. |
Volume: |
67 |
Issue: |
3 |
Pages: |
1203-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimojima M |
Year: |
2006 |
Journal: |
J Virol |
Title: |
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. |
Volume: |
80 |
Issue: |
20 |
Pages: |
10109-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marzi A |
Year: |
2006 |
Journal: |
J Virol |
Title: |
The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. |
Volume: |
80 |
Issue: |
13 |
Pages: |
6305-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ito H |
Year: |
2001 |
Journal: |
J Virol |
Title: |
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. |
Volume: |
75 |
Issue: |
3 |
Pages: |
1576-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sui J |
Year: |
2002 |
Journal: |
Virology |
Title: |
Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor. |
Volume: |
303 |
Issue: |
1 |
Pages: |
9-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wahl-Jensen VM |
Year: |
2005 |
Journal: |
J Virol |
Title: |
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. |
Volume: |
79 |
Issue: |
16 |
Pages: |
10442-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wahl-Jensen V |
Year: |
2005 |
Journal: |
J Virol |
Title: |
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. |
Volume: |
79 |
Issue: |
4 |
Pages: |
2413-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hwang M |
Year: |
2005 |
Journal: |
Gene Expr Patterns |
Title: |
The temporal and spatial expression of the novel Ca++-binding proteins, Scarf and Scarf2, during development and epidermal differentiation. |
Volume: |
5 |
Issue: |
6 |
Pages: |
801-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anastasio N |
Year: |
2010 |
Journal: |
Am J Hum Genet |
Title: |
Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome. |
Volume: |
87 |
Issue: |
4 |
Pages: |
553-9 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Proteins in this family include the envelope glycoprotein and the pre-small/secreted glycoprotein from Filoviridae []. The envelope glycoprotein can be cleaved into 3 chains: GP1, GP2 and GP2-delta.GP1 is responsible for binding to the receptor(s), such as CD209 and CLEC4M, on target cells. These interactions not only facilitate virus cell entry, but also allow capture of viral particles by dendritic cells (DCs) and subsequent transmission to susceptible cells without DCs infection (trans infection) [].GP2 acts as a class I viral fusion protein. It is responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane []. GP1,2 peplomers mediates endothelial cell activation and decreases endothelial barrier function. It mediates activation of primary macrophages. At terminal stages of the viral infection, when its expression is high, GP1,2 down-modulates the expression of various host cell surface molecules that are essential for immune surveillance and cell adhesion [].GP2delta is part of the complex GP1,2delta released by host ADAM17 metalloprotease. This secreted complex may play a role in the pathogenesis of the virus by efficiently blocking the neutralizing antibodies that would otherwise neutralize the virus surface glycoproteins GP1,2. Might therefore contribute to the lack of inflammatory reaction seen during infection in spite the of extensive necrosis and massive virus production. GP1,2delta does not seem to be involved in activation of primary macrophage [].pre-small/secreted glycoprotein sGP seems to possess an anti-inflammatory activity as it can reverse the barrier-decreasing effects of TNF alpha. It might therefore contribute to the lack of inflammatory reaction seen during infection in spite the of extensive necrosis and massive virus production. It does not seem to be involved in activation of primary macrophages. It does not seem to interact specifically with neutrophils [, , , ]. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
820
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
478
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
474
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
833
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
566
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
833
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Roy A |
Year: |
2012 |
Journal: |
Structure |
Title: |
Small terminase couples viral DNA binding to genome-packaging ATPase activity. |
Volume: |
20 |
Issue: |
8 |
Pages: |
1403-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carninci P |
Year: |
2005 |
Journal: |
Science |
Title: |
The transcriptional landscape of the mammalian genome. |
Volume: |
309 |
Issue: |
5740 |
Pages: |
1559-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huttlin EL |
Year: |
2010 |
Journal: |
Cell |
Title: |
A tissue-specific atlas of mouse protein phosphorylation and expression. |
Volume: |
143 |
Issue: |
7 |
Pages: |
1174-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Church DM |
Year: |
2009 |
Journal: |
PLoS Biol |
Title: |
Lineage-specific biology revealed by a finished genome assembly of the mouse. |
Volume: |
7 |
Issue: |
5 |
Pages: |
e1000112 |
|
•
•
•
•
•
|